Cellectis S.A.
CLLS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001627281
No open-market purchases or sales by Cellectis S.A. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $28.4M in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Cellectis S.A. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 28
- +4 vs. Q2 2025
- Shares held
- 8.31M
- −3.45M (−29.3%) vs. Q2 2025
- Total value
- $23.7M
- +$5.83M (+32.7%) vs. Q2 2025
- New holders
- 7
- 6 more added
- Sold out
- 3
- 6 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLLS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $28.4M |
| Q1 2026 | 32 | $32.5M |
| Q4 2025 | 34 | $51.1M |
| Q3 2025 | 28 | $23.7M |
| Q2 2025 | 24 | $17.9M |
| Q1 2025 | 27 | $16.9M |
| Q4 2024 | 29 | $23.0M |
| Q3 2024 | 27 | $20.9M |
| Q2 2024 | 27 | $18.3M |
| Q1 2024 | 31 | $26.1M |
| Q4 2023 | 34 | $30.2M |
| Q3 2023 | 31 | $18.1M |
| Q2 2023 | 36 | $27.6M |
| Q1 2023 | 34 | $29.3M |
| Q4 2022 | 40 | $18.3M |
| Q3 2022 | 50 | $23.6M |
| Q2 2022 | 45 | $30.6M |
| Q1 2022 | 51 | $55.8M |
| Q4 2021 | 57 | $123.7M |
| Q3 2021 | 70 | $194.1M |
| Q2 2021 | 78 | $250.6M |
| Q1 2021 | 81 | $308.0M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Cellectis S.A.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of America Corp | 77 | $220 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 100 | $285 | 0.00% | 00.0% | Unchanged |
| Principal Securities, Inc. | 179 | $510 | 0.00% | 00.0% | Unchanged |
| EverSource Wealth Advisors, LLC | 196 | $559 | 0.00% | +183+1,407.7% | Added |
| POM Investment Strategies, LLC | 495 | $1.41K | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 500 | $1.43K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 990 | $2.82K | 0.00% | +990 | New |
| Rhumbline Advisers | 1,455 | $4.15K | 0.00% | −450−23.6% | Reduced |
| Atlantic Union Bankshares Corp | 1,500 | $4.28K | 0.00% | +1,500 | New |
| Wells Fargo & Company | 3,150 | $8.98K | 0.00% | −14,000−81.6% | Reduced |
| National Bank of Canada | 3,600 | $10.1K | 0.00% | 00.0% | Unchanged |
| Harbour Investments, Inc. | 4,500 | $12.8K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 4,945 | $14.1K | 0.00% | +3,168+178.3% | Added |
| First Affirmative Financial Network | 10,149 | $28.9K | 0.01% | −9,636−48.7% | Reduced |
| Marshall Wace, LLP | 10,435 | $29.7K | 0.00% | +10,435 | New |
| Baird Financial Group, Inc. | 11,090 | $31.6K | 0.00% | +11,090 | New |
| Delaney Dennis R | 24,000 | $68.4K | 0.03% | +24,000 | New |
| Virtu Financial LLC | 25,211 | $72.0K | 0.00% | +25,211 | New |
| UBS Group AG | 29,299 | $83.5K | 0.00% | +3,670+14.3% | Added |
| BNP Paribas Arbitrage, SA | 41,300 | $117.7K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 53,865 | $153.5K | 0.00% | +19,432+56.4% | Added |
| Millennium Management LLC | 57,740 | $164.6K | 0.00% | +22,080+61.9% | Added |
| LPL Financial LLC | 85,147 | $242.7K | 0.00% | −515−0.6% | Reduced |
| Morgan Stanley | 87,675 | $249.9K | 0.00% | −5,120−5.5% | Reduced |
| Citadel Advisors LLC | 221,959 | $632.6K | 0.00% | +221,959 | New |
| Macquarie Group Ltd | 226,875 | $647.0K | 0.00% | 00.0% | Unchanged |
| B Group, Inc. | 3,281,501 | $9.35M | 8.94% | +25,000+0.8% | Added |
| Long Focus Capital Management, LLC | 4,123,262 | $11.8M | 0.67% | −594,031−12.6% | Reduced |
| UBS Asset Management Americas Inc | 0 | $0 | 0.00% | −3,178,620−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −11,747−100.0% | Sold out |
| Raymond James Financial Inc | 0 | $0 | 0.00% | −1,132−100.0% | Sold out |